MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-10-2026
Electromed Operating Income 2011-2026 | ELMD
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Electromed
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.66 M | 6.58 M | 4.01 M | 2.97 M | 3.14 M | 5.12 M | 2.83 M | 2.71 M | 3.57 M | 3.11 M | 1.31 M | -741 K | -1.83 M | 606 K | 1.87 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 9.66 M | -1.83 M | 2.99 M |
Quarterly Operating Income Electromed
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.62 M | 2.67 M | - | 2.14 M | 2.54 M | 1.94 M | - | 1.84 M | 2.26 M | 142 K | - | 1.2 M | 1.27 M | 44 K | 1.32 M | 863 K | 1.08 M | 538 K | 1.61 M | 243 K | 1.58 M | 663 K | 1.58 M | 663 K | 1.57 M | 1.35 M | 1.57 M | 1.35 M | 675 K | 202 K | 672 K | 199 K | 771 K | 99.2 K | 770 K | 162 K | 729 K | 289 K | 729 K | 289 K | 1.25 M | 585 K | 1.25 M | 585 K | 447 K | 398 K | 447 K | 398 K | -309 K | -577 K | -309 K | -577 K | -595 K | -96.4 K | -595 K | -96.4 K | 100 K | 452 K | 100 K | 452 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.62 M | -595 K | 781 K |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K |  USA |
 |
AdaptHealth Corp.
AHCO
|
90.9 M | $ 13.08 | 2.19 % | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
-71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
Cytosorbents Corporation
CTSO
|
-14.7 M | $ 0.61 | -2.58 % | $ 38 M | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 3.22 | - | $ 121 M |  France |
 |
ClearPoint Neuro
CLPT
|
-24.2 M | $ 11.21 | -4.84 % | $ 317 M | USA |
 |
Globus Medical
GMED
|
480 M | $ 93.7 | -1.24 % | $ 12.7 B | USA |
 |
Eargo
EAR
|
-112 M | - | - | $ 10.2 M | USA |
 |
Second Sight Medical Products
EYES
|
-27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
-10.6 M | - | -0.57 % | $ 7.12 M | USA |
 |
Helius Medical Technologies
HSDT
|
-12.4 M | $ 2.12 | -1.85 % | $ 1.29 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
-74.4 M | $ 5.48 | 2.81 % | $ 1.16 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-39.2 M | $ 15.82 | -2.29 % | $ 371 M | USA |
 |
Delcath Systems
DCTH
|
660 K | $ 10.84 | - | $ 388 M | USA |
 |
LivaNova PLC
LIVN
|
199 M | $ 63.41 | -1.23 % | $ 3.46 B |  Britain |
 |
IRIDEX Corporation
IRIX
|
-2.57 M | $ 1.08 | 1.89 % | $ 18.3 M | USA |
 |
LENSAR
LNSR
|
-24.6 M | $ 5.21 | 2.36 % | $ 62.3 M | USA |
 |
CONMED Corporation
CNMD
|
103 M | $ 37.87 | -1.23 % | $ 1.18 B | USA |
 |
Inspire Medical Systems
INSP
|
51 M | $ 55.07 | -2.2 % | $ 1.62 B | USA |
 |
Pulmonx Corporation
LUNG
|
-53.7 M | $ 1.28 | 0.79 % | $ 52.1 M | USA |
 |
Integer Holdings Corporation
ITGR
|
221 M | $ 85.35 | -0.78 % | $ 2.96 B | USA |
 |
Invacare Corporation
IVC
|
-80.5 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.26 B | $ 83.46 | -0.94 % | $ 48.8 B | USA |
 |
MiMedx Group
MDXG
|
63.9 M | $ 3.34 | -2.62 % | $ 494 M | USA |
 |
NanoVibronix
NAOV
|
-22.9 M | - | - | $ 1.08 M | USA |
 |
Nevro Corp.
NVRO
|
-126 M | - | - | $ 217 M | USA |
 |
Myomo
MYO
|
-14.4 M | $ 0.83 | 0.8 % | $ 34.7 M | USA |
 |
Cutera
CUTR
|
-156 M | - | -10.19 % | $ 1.99 M | USA |
 |
Natus Medical Incorporated
NTUS
|
23.8 M | - | 1.94 % | $ 1.05 B | USA |
 |
Orthofix Medical
OFIX
|
-81.4 M | $ 12.32 | -0.24 % | $ 488 M |  Curacao |